Annual Total Long Term Liabilities
$2.76 M
+$124.60 K+4.73%
01 December 2023
Summary:
NLS Pharmaceutics AG annual total long term liabilities is currently $2.76 million, with the most recent change of +$124.60 thousand (+4.73%) on 01 December 2023. During the last 3 years, it has fallen by -$231.00 thousand (-7.72%). NLSP annual total long term liabilities is now -69.38% below its all-time high of $9.02 million, reached on 31 December 2017.NLSP Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$2.74 M
-$17.10 K-0.62%
01 June 2024
Summary:
NLS Pharmaceutics AG quarterly total long term liabilities is currently $2.74 million, with the most recent change of -$17.10 thousand (-0.62%) on 01 June 2024. Over the past year, it has increased by +$79.00 thousand (+2.96%). NLSP quarterly long term liabilities is now -58.08% below its all-time high of $6.54 million, reached on 31 December 2018.NLSP Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NLSP Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.7% | +3.0% |
| 3 y3 years | -7.7% | -3.0% |
| 5 y5 years | -57.8% | +3.5% |
NLSP Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -7.7% | +4.7% | -3.0% | +4.1% |
| 5 y | 5 years | -57.8% | +4.7% | -15.7% | +4.1% |
| alltime | all time | -69.4% | +4.7% | -58.1% | +4.1% |
NLS Pharmaceutics AG Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $2.74 M(-0.6%) |
| Dec 2023 | $2.76 M(+4.7%) | $2.76 M(+3.6%) |
| June 2023 | - | $2.66 M(+1.1%) |
| Dec 2022 | $2.64 M(-6.5%) | $2.64 M(-2.0%) |
| June 2022 | - | $2.69 M(-4.6%) |
| Dec 2021 | $2.82 M | $2.82 M(-0.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | $2.83 M(-5.5%) |
| Dec 2020 | $2.99 M(+5.6%) | $2.99 M(-8.0%) |
| June 2020 | - | $3.25 M(+14.8%) |
| Dec 2019 | $2.83 M(-56.7%) | $2.83 M(+6.9%) |
| June 2019 | - | $2.65 M(-59.5%) |
| Dec 2018 | $6.54 M(-27.4%) | $6.54 M |
| Dec 2017 | $9.02 M | - |
FAQ
- What is NLS Pharmaceutics AG annual total long term liabilities?
- What is the all time high annual total long term liabilities for NLS Pharmaceutics AG?
- What is NLS Pharmaceutics AG annual total long term liabilities year-on-year change?
- What is NLS Pharmaceutics AG quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for NLS Pharmaceutics AG?
- What is NLS Pharmaceutics AG quarterly long term liabilities year-on-year change?
What is NLS Pharmaceutics AG annual total long term liabilities?
The current annual total long term liabilities of NLSP is $2.76 M
What is the all time high annual total long term liabilities for NLS Pharmaceutics AG?
NLS Pharmaceutics AG all-time high annual total long term liabilities is $9.02 M
What is NLS Pharmaceutics AG annual total long term liabilities year-on-year change?
Over the past year, NLSP annual total long term liabilities has changed by +$124.60 K (+4.73%)
What is NLS Pharmaceutics AG quarterly total long term liabilities?
The current quarterly long term liabilities of NLSP is $2.74 M
What is the all time high quarterly long term liabilities for NLS Pharmaceutics AG?
NLS Pharmaceutics AG all-time high quarterly total long term liabilities is $6.54 M
What is NLS Pharmaceutics AG quarterly long term liabilities year-on-year change?
Over the past year, NLSP quarterly total long term liabilities has changed by +$79.00 K (+2.96%)